Onderzoek naar optreden van hartfalen na een hartaanval.
- Conditions
- Hartfalen, myocardinfarct, genetica, biomarkers, bioinformatica, heart failure, myocardial infarction, genetics, bioinformatics, pathway
- Registration Number
- NL-OMON26126
- Lead Sponsor
- Dr. Folkert W. Asselbergs, cardiologistDepartment of Cardiology, Division Heart & LungsUniversity Medical Center UtrechtRoom E03.511P.O. Box 855003508 GA UtrechtThe Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2400
1. Patients admitted with an acute myocardial infarction and candidates for primary PCI. A diagnosis of acute myocardial infarction is defined by chest pain suggestive for myocardial ischemia for at least 30 minutes with a time from onset of symptoms of less than 24 hours before hospital admission and an ECG with ST segment elevation of more than 0.1mV in 2 or more leads;
2. Minimum age 18 years;
1. Presence of other serious medical conditions with a life expectancy of less than 6 months;
2. Unwilling to sign informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time till first hospitalization for heart failure or heart failure related mortality.
- Secondary Outcome Measures
Name Time Method 1. Reinfarction;<br /><br>2. Stent thrombosis;<br /><br>3. Arrhythmias;<br /><br>4. Cardiac mortality (including sudden cardiac arrest survivors);<br /><br>5. All-cause mortality;<br /><br>6. Combination of all endpoints.